No-code platform opens early access to generative binder design with [...]

Backing from Shawbrook follows rapid customer growth and positions Optibrium [...]

New alliance targets early 2026 for first-in-human trial of non-opioid [...]

20 global teams will receive early-stage funding and access to [...]

Vivodyne has secured $40 million in Series A funding to [...]

As generative AI rapidly evolves, one of its most promising [...]

Partnership aims to accelerate development using computational drug design Creyon [...]